Skip to main content

Eye Conditions News (Page 6)

Related terms: Eye Disorders

FDA Approves Hetlioz: First Treatment for Non-24 Hour Sleep-Wake Disorder in Blind Individuals

January 31, 2014 – The U.S. Food and Drug Administration today approved Hetlioz (tasimelteon), a melatonin receptor agonist, to treat non-24- hour sleep-wake disorder (“non-24”) in totally blind ind...

FDA Approves Jetrea for Symptomatic Vitreomacular Adhesion in the Eyes

October 18, 2012 – On Oct. 17, the U.S. Food and Drug Administration approved Jetrea (ocriplasmin), the first drug approved to treat an eye condition called symptomatic vitreomacular adhesion (VMA)....

Sigma-Tau Pharmaceuticals, Inc. Receives FDA Approval of Cystaran (cysteamine ophthalmic solution) 0.44%

GAITHERSBURG, MD, October 04, 2012 —Sigma-Tau Pharmaceuticals, Inc. announced today that the Company has received approval from the U.S. Food & Drug Administration (FDA) for Cystaran (cysteamine o...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Glaucoma, Eye Dryness / Redness, Macular Degeneration, Cataract

Related drug support groups

Rocephin